Table 1. Association of MARCH7 expression with clinicopathological characteristics in 158 patients of EOC.
| No. of patients | MARCH7 expression | P value | ||
|---|---|---|---|---|
| (n=158) | Low no.(%) | High no.(%) | ||
| Characteristics | ||||
| Age(years) | >0.5 | |||
| <50 | 83 | 36(43.37%) | 47(56.63%) | |
| ≥50 | 75 | 35(46.67%) | 40(53.33%) | |
| Normal ovarian | 20 | 18(90%) | 2(10%) | <0.05 |
| Cancer tissues | 138 | 79(57.25) | 59(42.75%) | |
| FIGO stage | ||||
| I/II | 103 | 74(71.84%) | 29(28.16%) | <0.001 |
| III/IV | 35 | 5(14.29%) | 30(85.71%) | |
| Grade | ||||
| 1 | 30 | 23(76.67%) | 7(23.33%) | |
| 2 | 36 | 24(66.67%) | 12(33.33%) | |
| 3 | 72 | 30(41.67%) | 42(58.33%) | |
| Grade 2-3 versus 1 | <0.05 | |||
| Tumor type | ||||
| Serous | 120 | 67(32.81%) | 53(67.19%) | |
| Mucinous | 14 | 11(81.25%) | 3(18.75%) | |
| Endometrioid | 4 | 1(75%) | 3(25%) | |
| Serous versus non-serous | ||||
| >0.005 | ||||